Wen-Hua He1, Yong Zhu1, Yin Zhu1, Pi Liu1, Hao Zeng1, Liang Xia1, Chen Yu2, Hai-Ming Chen3, Xu Shu1, Zhi-Jian Liu1, You-Xiang Chen1, Nong-Hua Lu4. 1. Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, 17 Yong Wai Zheng Street, Nanchang, 330006, Jiangxi, People's Republic of China. 2. Department of Radiology, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China. 3. Department of Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China. 4. Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, 17 Yong Wai Zheng Street, Nanchang, 330006, Jiangxi, People's Republic of China. lunonghua@ncu.edu.cn.
Abstract
BACKGROUND AND STUDY AIM: The commonly used minimally invasive methods for patients with infected pancreatic necrosis (IPN) are initial endoscopic transluminal drainage (ETD) and percutaneous catheter drainage (PCD), which are followed, if necessary, by endoscopic or surgical necrosectomy. This study intends to explore which of the two minimally invasive treatments leads to a better prognosis. PATIENTS AND METHODS: Patients with IPN and an indication for intervention were prospectively enrolled and underwent either initial ETD or PCD followed, if necessary, by endoscopic or surgical necrosectomy. RESULTS: Initial treatment success occurred in 8 of 11 patients after ETD (72.7%) and in 3 of 13 patients after PCD (30.8%) (risk ratio [RR] with ETD, 2.36; 95% CI 0.97-5.77; P = 0.04). After 1 year of follow-up, 72.7% of patients survived with ETD, and 69.2% survived with PCD (RR 1.05; 95% CI 0.63-1.75; P = 0.85). Intestinal fistula seems to have occurred less in the patients who received initial ETD rather than PCD therapy (9.1 vs. 38.5%; RR 0.24; 95% CI 0.03-1.73; P = 0.098). Fewer patients who underwent an initial ETD were transferred to surgery (9.1 vs. 46.2%; RR 0.20; 95% CI 0.03-1.40; P = 0.047). A higher rate of new-onset diabetes (3 cases) or impaired glucose tolerance (1 case) occurred in initial PCD compared to ETD (40 vs. 0%, P = 0.042). CONCLUSION: The outcomes of initial endoscopic transluminal drainage are superior to percutaneous drainage for patients with infected pancreatic necrosis (ChiCTR-ONRC-13003653).
BACKGROUND AND STUDY AIM: The commonly used minimally invasive methods for patients with infected pancreatic necrosis (IPN) are initial endoscopic transluminal drainage (ETD) and percutaneous catheter drainage (PCD), which are followed, if necessary, by endoscopic or surgical necrosectomy. This study intends to explore which of the two minimally invasive treatments leads to a better prognosis. PATIENTS AND METHODS: Patients with IPN and an indication for intervention were prospectively enrolled and underwent either initial ETD or PCD followed, if necessary, by endoscopic or surgical necrosectomy. RESULTS: Initial treatment success occurred in 8 of 11 patients after ETD (72.7%) and in 3 of 13 patients after PCD (30.8%) (risk ratio [RR] with ETD, 2.36; 95% CI 0.97-5.77; P = 0.04). After 1 year of follow-up, 72.7% of patients survived with ETD, and 69.2% survived with PCD (RR 1.05; 95% CI 0.63-1.75; P = 0.85). Intestinal fistula seems to have occurred less in the patients who received initial ETD rather than PCD therapy (9.1 vs. 38.5%; RR 0.24; 95% CI 0.03-1.73; P = 0.098). Fewer patients who underwent an initial ETD were transferred to surgery (9.1 vs. 46.2%; RR 0.20; 95% CI 0.03-1.40; P = 0.047). A higher rate of new-onset diabetes (3 cases) or impaired glucose tolerance (1 case) occurred in initial PCD compared to ETD (40 vs. 0%, P = 0.042). CONCLUSION: The outcomes of initial endoscopic transluminal drainage are superior to percutaneous drainage for patients with infected pancreatic necrosis (ChiCTR-ONRC-13003653).
Authors: Michael G T Raraty; Christopher M Halloran; Susanna Dodd; Paula Ghaneh; Saxon Connor; Jonathan Evans; Robert Sutton; John P Neoptolemos Journal: Ann Surg Date: 2010-05 Impact factor: 12.969
Authors: Sandra van Brunschot; Paul Fockens; Olaf J Bakker; Marc G Besselink; Rogier P Voermans; Jan-Werner Poley; Hein G Gooszen; Marco Bruno; Hjalmar C van Santvoort Journal: Surg Endosc Date: 2014-01-08 Impact factor: 4.584
Authors: Hjalmar C van Santvoort; Marc G Besselink; Olaf J Bakker; H Sijbrand Hofker; Marja A Boermeester; Cornelis H Dejong; Harry van Goor; Alexander F Schaapherder; Casper H van Eijck; Thomas L Bollen; Bert van Ramshorst; Vincent B Nieuwenhuijs; Robin Timmer; Johan S Laméris; Philip M Kruyt; Eric R Manusama; Erwin van der Harst; George P van der Schelling; Tom Karsten; Eric J Hesselink; Cornelis J van Laarhoven; Camiel Rosman; Koop Bosscha; Ralph J de Wit; Alexander P Houdijk; Maarten S van Leeuwen; Erik Buskens; Hein G Gooszen Journal: N Engl J Med Date: 2010-04-22 Impact factor: 91.245
Authors: Sujievvan Chandran; Marios Efthymiou; Arthur Kaffes; John Wei Chen; Vu Kwan; Michael Murray; David Williams; Nam Quoc Nguyen; William Tam; Christine Welch; Andre Chong; Saurabh Gupta; Ben Devereaux; Peter Tagkalidis; Frank Parker; Rhys Vaughan Journal: Gastrointest Endosc Date: 2014-08-02 Impact factor: 9.427
Authors: H Seifert; M Biermer; W Schmitt; C Jürgensen; U Will; R Gerlach; C Kreitmair; A Meining; T Wehrmann; T Rösch Journal: Gut Date: 2009-03-11 Impact factor: 23.059
Authors: Rogier P Voermans; Mariëlle C Veldkamp; Erik A Rauws; Marco J Bruno; Paul Fockens Journal: Gastrointest Endosc Date: 2007-11 Impact factor: 9.427
Authors: Sandra van Brunschot; Janneke van Grinsven; Rogier P Voermans; Olaf J Bakker; Marc G H Besselink; Marja A Boermeester; Thomas L Bollen; Koop Bosscha; Stefan A Bouwense; Marco J Bruno; Vincent C Cappendijk; Esther C Consten; Cornelis H Dejong; Marcel G W Dijkgraaf; Casper H van Eijck; G Willemien Erkelens; Harry van Goor; Mohammed Hadithi; Jan-Willem Haveman; Sijbrand H Hofker; Jeroen J M Jansen; Johan S Laméris; Krijn P van Lienden; Eric R Manusama; Maarten A Meijssen; Chris J Mulder; Vincent B Nieuwenhuis; Jan-Werner Poley; Rogier J de Ridder; Camiel Rosman; Alexander F Schaapherder; Joris J Scheepers; Erik J Schoon; Tom Seerden; B W Marcel Spanier; Jan Willem A Straathof; Robin Timmer; Niels G Venneman; Frank P Vleggaar; Ben J Witteman; Hein G Gooszen; Hjalmar C van Santvoort; Paul Fockens Journal: BMC Gastroenterol Date: 2013-11-25 Impact factor: 3.067
Authors: Lu Ke; Wenjian Mao; Jing Zhou; Bo Ye; Gang Li; Jingzhu Zhang; Peng Wang; Zhihui Tong; John Windsor; Weiqin Li Journal: World J Surg Date: 2019-04 Impact factor: 3.352